HOLLAND & KNIGHT LLP for UNITED MITOCHONDRIAL DISEASE FOUNDATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Equity Act; Advancing Kids Access to Care Act; Rare Pediatric Disease Voucher Review Program; Telehealth Authority extension.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT HUNT BRADNER | — |
| MIRANDA FRANCO | — |
| ABIGAIL HEMENWAY | — |
Budget/Appropriations BUD
FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT HUNT BRADNER | — |
| MIRANDA FRANCO | — |
| ABIGAIL HEMENWAY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.